A multicentre, international, randomised, open-label phase 3 trial of avelumab + best supportive care (BSC) vs BSC alone as maintenance therapy after first-line platinum-based chemotherapy in patients with advanced urothelial cancer (JAVELIN bladder 100)

Publication | Open Access

DOI Full Paper Access

Citations

References

2016

Year

Thomas Powles, Petros Grivas, Jeanny B. Aragon‐Ching, Yacoub Faroun, Elizabeth R. Kessler, Yoshihiko Tomita, D. Chakrabarti, Robert J Laliberte, Michael Shnaidman, Daniel P. Petrylak

Annals of Oncology